Director/PDMR Shareholding

Plant Health Care PLC
27 September 2007


                     PLANT HEALTH CARE PLC (THE 'COMPANY')                      

                  ALLOTMENT OF SHARES/ DIRECTORS' SHAREHOLDINGS

27 September 2007

NON-EXECUTIVE DIRECTORS' REMUNERATION

On 25 September 2007, the Company approved the allotment of ordinary shares of
9,354 ordinary shares of 1p ('Ordinary Shares') to the following non-executive
directors, in accordance with the Company's existing contractual arrangements,
which comprise part of the non-executive directors' remuneration packages and
are payable in lieu of a part of their salary. The shares were allotted at
248.5p per share, calculated at the closing middle market price derived from the
Daily Official List on 24 September 2007.

+--------------------+----------------------+-------------------+
|Non-executive       |Value of remuneration |Number of Ordinary |
|director            |used to purchase      |Shares allotted    |
|                    |shares                |                   |
+--------------------+----------------------+-------------------+
|Dr Albert Fischer   |             £9,500.00|              3,822|
+--------------------+----------------------+-------------------+
|Dr Robert Chanson   |             £6,875.00|              2,766|
+--------------------+----------------------+-------------------+
|Thomas Isler        |             £6,875.00|              2,766|
+--------------------+----------------------+-------------------+

Following the above allotments, the Company was notified today that on 25
September 2007 Dr Chanson had sold 2,766 Ordinary Shares in an off-market
transaction at a price of
248.5 pence per Ordinary Share. His resultant holding in the Company is 135,166
Ordinary Shares, which is 0.30 per cent. of the total issued share capital in
the Company.

The Company was also notified today that on 24 September 2007 Dr Fischer
transferred 53,775 Ordinary Shares registered in the name of his personal
holding company into his own name. There was no change in his beneficial
interest in the Company, which remains at 151,092 Ordinary Shares, which is 0.34
per cent of the total issued share capital in the Company.

Following the above-mentioned allotments and transactions, the beneficial
interests of the directors concerned in the ordinary share capital of the
Company are as shown below:

+-------------------+-------------------+-------------------+------------------+
|Name               |Ordinary Share     |Percentage of      |Share Options     |
|                   |holding            |issued Ordinary    |                  |
|                   |                   |Share capital      |                  |
+-------------------+-------------------+-------------------+------------------+
|Dr Albert Fischer  |151,092            |0.34               |225,000           |
+-------------------+-------------------+-------------------+------------------+
|Dr Robert Chanson  |135,166            |0.30               |210,000           |
+-------------------+-------------------+-------------------+------------------+
|Thomas Isler       |406,654            |0.92               |202,500           |
+-------------------+-------------------+-------------------+------------------+

 

Application has been made for 9,354 Ordinary Shares (the 'New Shares') to be
admitted to trading on AIM and admission is expected to occur on 2 October 2007.
The New Shares will rank pari passu with the Company's existing Ordinary Shares.

 

Following admission of the New Shares, the total issued share capital of the
Company will be 44,176,729 Ordinary Shares, all of which have voting rights.
 
The above figure (44,176,729) may be used by shareholders as the denominator for
the calculations by which they will determine if they are required to notify 
their interest in, or a change to their interest in, Plant Health Care plc 
under the FSA's Disclosure and Transparency Rules.  


27 September 2007
Andrew C. Wood FCIS                                      [phone]
Company Secretary                                                            

 



                      This information is provided by RNS
            The company news service from the London Stock Exchange